Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Cureus|April 7, 2025
Subclinical Presentation of Cutibacterium acnes Infection Following Revision Rotator Cuff SurgeryZachary Walker, David Shuster, David Sosnoski, et al.American Journal of Community Psychology|November 4, 2016
The California Linkages Program: Doorway to Housing Support for Child Welfare-Involved ParentsAmy D'Andrade, James David Simon, Danna Fabella, et al.Journal of Chromatography. A|March 8, 2013
Liquid chromatography coupled with tandem mass spectrometry for the bioanalysis of proteins in drug development: practical considerations in assay development and validationGuowen Liu, Qin C Ji, Robert Dodge, et al.Bioorganic & Medicinal Chemistry Letters|July 2, 2014
Discovery of acylurea isosteres of 2-acylaminothiadiazole in the azaxanthene series of glucocorticoid receptor agonistsHua Gong, Michael Yang, Zili Xiao, et al.Journal of Medicinal Chemistry|September 9, 2011
Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826)David S Weinstein, Hua Gong, Arthur M Doweyko, et al.Journal of Medicinal Chemistry|November 16, 2010
Dimethyl-diphenyl-propanamide derivatives as nonsteroidal dissociated glucocorticoid receptor agonistsBingwei V Yang, David S Weinstein, Lidia M Doweyko, et al.International Journal of Toxicology|June 3, 2022
Increasing the Reuse of Protein Non-Naïve Nonhuman Primates in Pharmaceutical Drug Discovery and Development: An Overview and Industry Position on the Challenges and BenefitsCharles Mattis, Natalie Bratcher, Monika Burns, et al.Journal of Medicinal Chemistry|April 24, 2015
Improving the pharmacokinetic and CYP inhibition profiles of azaxanthene-based glucocorticoid receptor modulators-identification of (S)-5-(2-(9-fluoro-2-(4-(2-hydroxypropan-2-yl)phenyl)-5H-chromeno[2,3-b]pyridin-5-yl)-2-methylpropanamido)-N-(tetrahydro-2H-pyran-4-yl)-1,3,4-thiadiazole-2-carboxamide (BMS-341)Michael G Yang, T G Murali Dhar, Zili Xiao, et al.Journal of Medicinal Chemistry|December 28, 2020
Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2Chunjian Liu, James Lin, Charles Langevine, et al.Scientific Reports|March 27, 2024
Present-day thermal and water activity environment of the Mars Sample Return collectionMaria-Paz Zorzano, Germán Martínez, Jouni Polkko, et al.Pageof 2